Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Long-Term Debt Repayments: 2015-2018

Historic Long-Term Debt Repayments for Editas Medicine (EDIT) over the last 4 years, with Dec 2018 value amounting to $857,000.

  • Editas Medicine's Long-Term Debt Repayments was N/A to $2.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of $857,000 for FY2018, which is 12.17% up from last year.
  • According to the latest figures from FY2018, Editas Medicine's Long-Term Debt Repayments is $857,000, which was up 12.17% from $764,000 recorded in FY2017.
  • In the past 5 years, Editas Medicine's Long-Term Debt Repayments registered a high of $2.0 million during FY2015, and its lowest value of $560,000 during FY2016.
  • For the 3-year period, Editas Medicine's Long-Term Debt Repayments averaged around $727,000, with its median value being $764,000 (2017).
  • As far as peak fluctuations go, Editas Medicine's Long-Term Debt Repayments slumped by 72.00% in 2016, and later surged by 36.43% in 2017.
  • Over the past 4 years, Editas Medicine's Long-Term Debt Repayments (Yearly) stood at $2.0 million in 2015, then tumbled by 72.00% to $560,000 in 2016, then skyrocketed by 36.43% to $764,000 in 2017, then grew by 12.17% to $857,000 in 2018.